Literature DB >> 21421711

Incidental focal 18F-FDG uptake in the pituitary gland: clinical significance and differential diagnostic criteria.

Seung Hyup Hyun1, Joon Young Choi, Kyung-Han Lee, Yearn Seong Choe, Byung-Tae Kim.   

Abstract

UNLABELLED: The purpose of this study was to identify the incidence and clinical significance of incidental pituitary uptake on whole-body (18)F-FDG PET/CT.
METHODS: We evaluated 13,145 consecutive subjects who underwent (18)F-FDG PET/CT. The final diagnosis of pathologic or physiologic uptake was based on brain MRI and follow-up PET scanning. Receiver-operating-characteristic curve analysis was performed to determine an optimal cutoff for detecting pathologic uptake.
RESULTS: We found that 107 (0.8%) subjects showed incidental pituitary uptake. In 29 of 71 subjects with the final diagnosis, the pituitary uptake was pathologic: macroadenomas (n = 21), microadenomas (n = 5), and malignancy (n = 3). When a maximum standardized uptake value of 4.1 was used as an optimal criterion for detecting pathologic uptake, the diagnostic sensitivity, specificity, and accuracy were 96.6%, 88.1%, and 91.5%, respectively.
CONCLUSION: Although incidental pituitary uptake is an unusual finding, the degree of (18)F-FDG accumulation is helpful in identifying pathologic pituitary lesions that warrant further diagnostic evaluation.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21421711     DOI: 10.2967/jnumed.110.083733

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  24 in total

1.  Differential diagnosis and management of a pituitary mass with renal cell carcinoma.

Authors:  Joo Min Hwang; Yong Hwy Kim; Tae Min Kim; Sung Hye Park
Journal:  J Korean Neurosurg Soc       Date:  2013-08-31

2.  Multicentre study of 18F-FDG-PET/CT prostate incidental uptake.

Authors:  Francesco Bertagna; Arnoldo Piccardo; Bassam Dib; Mattia Bertoli; Federica Fracassi; Giovanni Bosio; Raffaele Giubbini; Giorgio Biasiotto; Luca Giovanella; Giorgio Treglia
Journal:  Jpn J Radiol       Date:  2015-07-08       Impact factor: 2.374

Review 3.  Diagnosis of Cushing's disease.

Authors:  Eleni Daniel; John D C Newell-Price
Journal:  Pituitary       Date:  2015-04       Impact factor: 4.107

Review 4.  Prevalence and clinical significance of incidental F18-FDG breast uptake: a systematic review and meta-analysis.

Authors:  Francesco Bertagna; Giorgio Treglia; Emanuela Orlando; Lodovica Dognini; Luca Giovanella; Ramin Sadeghi; Raffaele Giubbini
Journal:  Jpn J Radiol       Date:  2013-12-13       Impact factor: 2.374

Review 5.  Metabolic In Vivo Visualization of Pituitary Adenomas: a Systematic Review of Imaging Modalities.

Authors:  Amy Yao; Priti Balchandani; Raj K Shrivastava
Journal:  World Neurosurg       Date:  2017-04-28       Impact factor: 2.104

6.  High-resolution(18)F-fluorodeoxyglucose positron emission tomography and magnetic resonance imaging for pituitary adenoma detection in Cushing disease.

Authors:  Prashant Chittiboina; Blake K Montgomery; Corina Millo; Peter Herscovitch; Russell R Lonser
Journal:  J Neurosurg       Date:  2014-12-05       Impact factor: 5.115

7.  Predictors of pathologic outcome of focal FDG uptake in the parotid gland identified on whole-body FDG PET imaging.

Authors:  Marc C Mabray; Spencer C Behr; David M Naeger; Robert R Flavell; Christine M Glastonbury
Journal:  Clin Imaging       Date:  2015-07-16       Impact factor: 1.605

8.  Diffuse thyroid uptake incidentally found on 18F-fluorodeoxyglucose positron emission tomography in subjects without cancer history.

Authors:  Ji Young Lee; Joon Young Choi; Yoon-Ho Choi; Seung Hyup Hyun; Seung Hwan Moon; Su Jin Jang; Yearn Seong Choe; Kyung-Han Lee; Byung-Tae Kim
Journal:  Korean J Radiol       Date:  2013-05-02       Impact factor: 3.500

Review 9.  Evidence-based management of incidental focal uptake of fluorodeoxyglucose on PET-CT.

Authors:  Deborah Pencharz; Malavika Nathan; Thomas L Wagner
Journal:  Br J Radiol       Date:  2018-01-31       Impact factor: 3.039

10.  Corticotropin releasing hormone can selectively stimulate glucose uptake in corticotropinoma via glucose transporter 1.

Authors:  Jie Lu; Blake K Montgomery; Grégoire P Chatain; Alejandro Bugarini; Qi Zhang; Xiang Wang; Nancy A Edwards; Abhik Ray-Chaudhury; Marsha J Merrill; Russell R Lonser; Prashant Chittiboina
Journal:  Mol Cell Endocrinol       Date:  2017-10-03       Impact factor: 4.102

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.